Cube Labs: admission application submitted for the listing of its ordinary shares and warrants on Euronext Growth Milan pro

Rome, March 15th, 2023 - Cube Labs S.p.A. ("Cube Labs" or the "Company") - an Italian venture builder in the healthcare technology sector - announced that it has submitted to…

Continue ReadingCube Labs: admission application submitted for the listing of its ordinary shares and warrants on Euronext Growth Milan pro

Cartilago receives “Notice of allowance” in the USA for its regenerative medicine patent application for osteoarthritis and dermal indications

27 February 2023ROME, Italy Cartilago SRL (”Cartilago”), a clinical stage regenerative medicine company founded by Cube Labs, announced today that the United States Patent & Trademark Office (”USPTO”) has issued…

Continue ReadingCartilago receives “Notice of allowance” in the USA for its regenerative medicine patent application for osteoarthritis and dermal indications

Cube Labs extends strategic partnership with INBB for translating commercially promising academic technologies into healthcare solutions

17 November 2022 – Cube Labs, the first venture builder in the healthcare technology space in Italy, announced today that it has extended its strategic partnership with the Italian National…

Continue ReadingCube Labs extends strategic partnership with INBB for translating commercially promising academic technologies into healthcare solutions

Cartilago announces clinical study results confirming the efficacy of regen longevity in reducing periocular wrinkles

Rome, Italy  11th November, 2022 – Cartilago, a clinical stage regenerative medicine company founded by Cube Labs, announced today the results from an analysis of 21 subjects with a mean…

Continue ReadingCartilago announces clinical study results confirming the efficacy of regen longevity in reducing periocular wrinkles